BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3911973)

  • 1. Ploidy disturbances in endometrial and ovarian carcinomas. A review.
    Iversen OE; Laerum OD
    Anal Quant Cytol Histol; 1985 Dec; 7(4):327-36. PubMed ID: 3911973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia.
    Michael H; Kotylo PK; Mohr M; Roth LM
    Am J Clin Pathol; 1996 Jul; 106(1):22-8. PubMed ID: 8701927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
    Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
    Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
    Smit VT; Fleuren GJ; van Houwelingen JC; Zegveld ST; Kuipers-Dijkshoorn NJ; Cornelisse CJ
    Cancer; 1990 Oct; 66(8):1843-9. PubMed ID: 2208040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
    Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
    Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
    Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
    Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosomes in adenomatous hyperplasia and adenocarcinoma of the endometrium].
    Bonilla-Musoles F
    Z Geburtshilfe Gynakol; 1971 Dec; 175(3):218-25. PubMed ID: 5157072
    [No Abstract]   [Full Text] [Related]  

  • 11. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ploidy as a prognostic factor in ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MH
    Int J Gynecol Pathol; 1983; 2(1):55-63. PubMed ID: 6307906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
    el-Naggar AK; Pathak S
    Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma.
    Kysela B; Siracký J; Redecha M; Bárdos A
    Neoplasma; 1990; 37(5):489-95. PubMed ID: 2234210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor heterogeneity in DNA ploidy of renal cell carcinomas as revealed by static cytofluorometry and flow cytometry].
    Kushima M; Konishi T; Okada Y; Tomoyoshi T; Kushima R; Hattori T
    Nihon Hinyokika Gakkai Zasshi; 1994 Mar; 85(3):473-80. PubMed ID: 8170079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
    Konski AA; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Mah J; Eggleston W
    Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics of gynecologic neoplasms.
    Wakonig-Vaartaja T; Auersperg N
    Clin Obstet Gynecol; 1970 Dec; 13(4):813-30. PubMed ID: 4930554
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
    Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
    Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.